Federica Guffanti

Mario Negri Institute for Pharmacological Research — Italy

Medicine · Health Sciences

16h-index901citations75works4.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(29), DNA Repair Mechanisms(15), PARP inhibition in cancer therapy(14), Cancer Genomics and Diagnostics(11), Cancer-related Molecular Pathways(8)

Publications75 total

Onvansertib-Based Second-Line Therapies in Combination with Gemcitabine and Carboplatin in Patient-Derived Platinum-Resistant Ovarian Carcinomas
International Journal of Molecular Sciences·2025· 2 citedOpen Access
Detection of aberrant locomotor activity in a mouse model of lung cancer via home cage monitoring
Frontiers in Oncology·2024Open Access
Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches
Frontiers in Oncology·2024· 16 citedOpen Access
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas
Cell Death and Disease·2024· 14 citedOpen Access
BRCA1 foci test as a predictive biomarker of olaparib response in ovarian cancer patient-derived xenograft models
Frontiers in Pharmacology·2024· 2 citedOpen Access
Tuning of Ultrasmall Gold Nanoparticles Surface Properties Affect Their Biological Fate
Particle & Particle Systems Characterization·2024· 4 citedOpen Access
Abstract 945: <i>In vivo</i> anti-tumor activity of onvansertib, a PLK1 inhibitor, combined with gemcitabine or carboplatin in platinum- resistant ovarian carcinoma patient-derived xenograft models
Cancer Research·2024
Different Patterns of Platinum Resistance in Ovarian Cancer Cells with Homologous Recombination Proficient and Deficient Background
International Journal of Molecular Sciences·2024· 4 citedOpen Access
Intermittent Fasting Enhances the Antitumor Activity of Cisplatin and Metformin Combination in Therapy-Resistant Ovarian Cancer PDXs
SSRN Electronic Journal·2024Open Access
Epithelioid Mesothelioma Patients with Very Long Survival Display Defects in DNA Repair
Cancers·2023· 3 citedOpen Access
Supplementary Figure 2 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Tables 1 through 6 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Figure 2 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Data from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Figure 1 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Figure 3 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Figure 3 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Information from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
Supplementary Figure 5 from Patient-Derived Ovarian Tumor Xenografts Recapitulate Human Clinicopathology and Genetic Alterations
2023Open Access
page 1 of 4Next →

Frequent Co-authors

Giovanna Damia(44), Francesca Ricci(20), Robert Fruscio(18), Monica Ganzinelli(13), Raffaella Giavazzi(12), Michela Chiappa(11), Francesca Bizzaro(10), Maria Rosa Bani(10), Alessandra Decio(9), Patrizia Perego(9), Massimo Broggini(9), Eliana Rulli(9), Carmen Ghilardi(8), Paola Ostano(8), Giovanna Chiorino(8), Rosaria Chilà(7), Marta Cesca(6), Alessandro Buda(6), Rodolfo Milani(6), Maddalena Fratelli(6)